[
1. Sanchis-Gomar F, Perez-Quilis C, Leischik R, Lucia A. Epidemiology of coronary heart disease and acute coronary syndrome. Ann Transl Med 2016; 4(13): 256.10.21037/atm.2016.06.33495872327500157
]Search in Google Scholar
[
2. Boulghobra D, Coste F, Geny B, Reboul C. Exercise training protects the heart against ischemia-reperfusion injury: A central role for mitochondria? Free Radic Biol Med 2020; 152: 395-410.
]Search in Google Scholar
[
3. Wu MY, Yiang GT, Liao WT, Tsai AP, Cheng YL, Cheng PW, et al. Current Mechanistic Concepts in Ischemia and Reperfusion Injury. Cell Physiol Biochem 2018; 46(4): 1650-67.10.1159/00048924129694958
]Search in Google Scholar
[
4. Li WA, Ding Y. Cardiac preconditioning and cardiovascular diseases. Heart Mind 2017; 1: 17-21.
]Search in Google Scholar
[
5. Thijssen DHJ, Redington A, George KP, Hopman MTE, Jones H. Association of Exercise Preconditioning With Immediate Cardioprotection: A Review. JAMA Cardiol 2018; 3(2): 169-76.10.1001/jamacardio.2017.449529188285
]Search in Google Scholar
[
6. Simonovic N, Jakovljevic V, Jeremic J, Finderle Z, Srejovic I, Nikolic Turnic T,et al. Comparative effects of calcium and potassium channel modulators on ischemia/ reperfusion injury in the isolated rat heart. Mol Cell Biochem 2019; 450(1-2): 175-85.10.1007/s11010-018-3384-y29922947
]Search in Google Scholar
[
7. Nogueira-Ferreira R, Moreira-Gonçalves D, Silva AF, Duarte JA, Leite-Moreira A, Ferreira R, et al. Exercise preconditioning prevents MCT-induced right ventricle remodeling through the regulation of TNF superfamily cytokines. Int J Cardiol 2016; 203: 858-66.10.1016/j.ijcard.2015.11.06626599752
]Search in Google Scholar
[
8. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med 2007; 357: 1121–35.10.1056/NEJMra07166717855673
]Search in Google Scholar
[
9. Ovize M, Baxter GF, Di Lisa F, Ferdinandy P, Garcia- Dorado D, Hausenloy DJ, et al. Working Group of Cellular Biology of Heart of European Society of Cardiology. Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res 2010; 87: 406–23.10.1093/cvr/cvq12920448097
]Search in Google Scholar
[
10. Kleinbongard P, Heusch G. Extracellular signalling molecules in the ischaemic/reperfused heart - druggable and translatable for cardioprotection? Br J Pharmacol 2015; 172(8): 2010-25.
]Search in Google Scholar
[
11. Goto M, Liu Y, Yang XM, Ardell JL, Cohen MV, Downey JM. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res 1995; 77: 611–21.10.1161/01.RES.77.3.611
]Search in Google Scholar
[
12. Eitel I, Stiermaier T, Rommel KP, Fuernau G, Sandri M, Mangner N, et al. Cardioprotection by combined intrahospital remote ischaemic perconditioning and postconditioning in ST- elevation myocardial infarction: the randomized LIPSIA CONDITIONING trial. Eur Heart J 2015; 36: 3049–57.10.1093/eurheartj/ehv46326385956
]Search in Google Scholar
[
13. Kokkonen JO, Kuoppala A, Saarinen J, Lindstedt KA, Kovanen PT. Kallidin- and bradykinin-degrading pathways in human heart. Circulation 1999; 99: 1984–90.10.1161/01.CIR.99.15.1984
]Search in Google Scholar
[
14. Kokkonen JO, Lindstedt KA, Kuoppala A, Kovanen PT. Kinin-degrading pathways in the human heart. Trends Cardiovasc Med 2000; 10: 42–45.10.1016/S1050-1738(00)00034-7
]Search in Google Scholar
[
15. Jalowy A, Schulz R, Dörge H, Behrends M, Heusch G. Infarct size reduction by AT1-receptor blockade through a signal cascade of AT2-receptor activation, bradykinin and prostaglandins in pigs. J Am Coll Cardiol 1998; 32: 1787–96.10.1016/S0735-1097(98)00441-0
]Search in Google Scholar
[
16. Penna C, Mancardi D, Tullio F, Pagliaro P. Postconditioning and intermittent bradykinin induced cardioprotection require cyclooxygenase activation and prostacyclin release during reperfusion. Basic Res Cardiol 2008; 103: 368–77.10.1007/s00395-007-0695-7
]Search in Google Scholar
[
17. Linz W, Wiemer G, Schölkens BA. Beneficial effects of bradykinin on myocardial energy metabolism and infarct size. Am J Cardiol 1997; 80: 118A–23A.10.1016/S0002-9149(97)00466-9
]Search in Google Scholar
[
18. Schoemaker RG, van Heijningen CL. Bradykinin mediates cardiac preconditioning at a distance. Am J Physiol Heart Circ Physiol 2000; 278: H1571–H76.10.1152/ajpheart.2000.278.5.H1571
]Search in Google Scholar
[
19. Weidenbach R, Schulz R, Gres P, Behrends M, Post H, Heusch G. Enhanced reduction of myocardial infarct size by combined ACE inhibition and AT(1)-receptor antagonism. Br J Pharmacol 2000; 131: 138–44.10.1038/sj.bjp.0703544
]Search in Google Scholar
[
20. Krieg T, Cui L, Qin Q, Cohen MV, Downey JM. Mitochondrial ROS generation following acetylcholine-induced EGF receptor transactivation requires metalloproteinase cleavage of proHB-EGF. J Mol Cell Cardiol 2004; 36: 435–43.10.1016/j.yjmcc.2003.12.013
]Search in Google Scholar
[
21. Papatheodorou I, Galatou E, Panagiotidis GD, Ravingerová T, Lazou A. Cardioprotective Effects of PPARβ/δ Activation against Ischemia/Reperfusion Injury in Rat Heart Are Associated with ALDH2 Upregulation, Amelioration of Oxidative Stress and Preservation of Mitochondrial Energy Production. Int J Mol Sci 2021; 22(12):6399.10.3390/ijms22126399
]Search in Google Scholar
[
22. Cui W, Xin S, Zhu L, Wang M, Hao Y, Zhao Y, et al. Si-Miao-Yong-An Decoction Maintains the Cardiac Function and Protects Cardiomyocytes from Myocardial Ischemia and Reperfusion Injury. Evid Based Complement Alternat Med. 2021; 2021:8968464.10.1155/2021/8968464
]Search in Google Scholar
[
23. Ji L, Zhang X, Liu W, et al. AMPK-regulated and Aktdependent enhancement of glucose uptake is essential in ischemic preconditioning-alleviated reperfusion injury. PLoS One 2013; 8(7): e69910.10.1371/journal.pone.0069910
]Search in Google Scholar
[
24. Tomai F, Crea F, Gaspardone A, Versaci F, De Paulis R, Penta de Peppo A, et al. Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP- sensitive K+ channel blocker. Circulation 1994; 90: 700–5.10.1161/01.CIR.90.2.700
]Search in Google Scholar
[
25. Liu Y, Tsuchida A, Cohen MV, Downey JM. Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts. J Mol Cell Cardiol 1995; 27: 883–92.10.1016/0022-2828(95)90038-1
]Search in Google Scholar
[
26. Pugsley MK. The diverse molecular mechanisms responsible for the actions of opioids on the cardiovascular system. Pharmacol Ther 2002; 93: 51–75.10.1016/S0163-7258(02)00165-1
]Search in Google Scholar
[
27. Ikeda Y, Miura T, Sakamoto J, Miki T, Tanno M, Kobayashi H, et al. Activation of ERK and suppression of calcineurin are interacting mechanisms of cardioprotection afforded by delta-opioid receptor activation. Basic Res Cardiol 2006; 101: 418–26.10.1007/s00395-006-0595-216619106
]Search in Google Scholar
[
28. Schultz JE, Rose E, Yao Z, Gross GJ. Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol 1995; 268: H2157–H61.10.1152/ajpheart.1995.268.5.H2157
]Search in Google Scholar
[
29. Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an irondependent form of nonapoptotic cell death. Cell 2012; 149: 1060-7210.1016/j.cell.2012.03.042336738622632970
]Search in Google Scholar
[
30. Tang D, Kroemer G. Ferroptosis Curr Biol 2020; 30: R1292–710.1016/j.cub.2020.09.068
]Search in Google Scholar
[
31. Xie Y, Zhu S, Song X, Sun X, Fan Y, Liu J, et al. The tumor suppressor p53 limits ferroptosis by blocking DPP4 activity. Cell Rep 2017; 20: 1692–704.10.1016/j.celrep.2017.07.05528813679
]Search in Google Scholar
[
32. Kardami E, Detillieux K, Ma X, Jiang Z, Santiago JJ, Jimenez SK, et al. Fibroblast growth factor-2 and cardioprotection. Heart Fail Rev 2007; 12: 267–77.10.1007/s10741-007-9027-017516168
]Search in Google Scholar
[
33. Kudej RK, Shen YT, Peppas AP, Huang CH, Chen W, Yan L, et al. Obligatory role of cardiac nerves and alpha1- adrenergic receptors for the second window of ischemic preconditioning in conscious pigs. Circ Res 2006; 99: 1270–76.10.1161/01.RES.0000251282.79411.4417068289
]Search in Google Scholar
[
34. Salie R, Moolman JA, Lochner A. The mechanism of beta-adrenergic preconditioning: roles for adenosine and ROS during triggering and mediation. Basic Res Cardiol 2012; 107: 281.10.1007/s00395-012-0281-522797560
]Search in Google Scholar
[
35. Cao, B., Wang, H., Zhang, C., et al. Remote ischemic postconditioning (RIPC) of the upper arm results in protection from cardiac ischemia– reperfusion injury following primary percutaneous coronary intervention (PCI) for acute ST- segment elevation myocardial infarction (STEMI). Med. Sci. Monit 2018; 24: 1017–26.
]Search in Google Scholar
[
36. Shimizu M, Tropak M, Diaz RJ, Suto F, Surendra H, Kuzmin E,et al. Transient limb ischaemia remotely preconditions through a humoral mechanism acting directly on the myocardium: evidence suggesting cross-species protection. Clin Sci (Lond) 2009; 117: 191–200.10.1042/CS2008052319175358
]Search in Google Scholar
[
37. Deutsch E, Berger M, Kussmaul WG, Hirshfeld JW Jr, Herrmann HC, Laskey WK. Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic features. Circulation 1990; 82: 2044–51.10.1161/01.CIR.82.6.2044
]Search in Google Scholar
[
38. DP, Pugsley WB, Alkhulaifi AM, Kemp M, Hooper J, Yellon DM. Ischaemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery. Heart 1997; 77: 314–18.10.1136/hrt.77.4.3144847239155608
]Search in Google Scholar
[
39. Traverse JH, Swingen CM, Henry TD, Fox J, Wang YL, Chavez IJ, et al. NHLBI- sponsored randomized trial of postconditioning during primary percutaneous coronary intervention for ST- elevation myocardial infarction. Circ. Res 2019; 124: 769–78.
]Search in Google Scholar
[
40. Higashi Y, Sasaki S, Kurisu S, Yoshimizu A, Sasaki N, Matsuura H, et al. Regular aerobic exercise augments endothelium-dependent vascular relaxation in normotensive as well as hypertensive subjects: role of endotheliumderived nitric oxide. Circulation 1999; 100(11): 1194–202.10.1161/01.CIR.100.11.1194
]Search in Google Scholar
[
41. Walsh JH, Yong G, Cheetham C, Watts GF, O’Driscoll GJ, Taylor RR, et al. Effects of exercise training on conduit and resistance vessel function in treated and untreated hypercholesterolaemic subjects. Eur Heart J 2003; 24(18): 1681–9.10.1016/S0195-668X(03)00384-1
]Search in Google Scholar
[
42. Gokce N, Vita JA, Bader DS, Sherman DL, Hunter LM, Holbrook M, et al. Effect of exercise on upper and lower extremity endothelial function in patients with coronary artery disease. Am J Cardiol 2002; 90(2): 124–7.10.1016/S0002-9149(02)02433-5
]Search in Google Scholar
[
43. Staat P, Rioufol G, Piot C, Cottin Y, Cung TT, L’Huillier I., et al. Postconditioning the human heart. Circulation 2005; 112: 2143–48.10.1161/CIRCULATIONAHA.105.55812216186417
]Search in Google Scholar
[
44. Buscemi S, Canino B, Batsis JA, Buscemi C, Calandrino V, Mattina A, et al. Relationships between maximal oxygen uptake and endothelial function in healthy male adults: a preliminary study. Acta Diabetol 2013; 50(2): 135–41.10.1007/s00592-010-0229-x20953639
]Search in Google Scholar
[
45. Edwards DG, Schofield RS, Lennon SL, Pierce GL, Nichols WW, Braith RW. Effect of exercise training on endothelial function in men with coronary artery disease. Am J Cardiol 2004; 93(5): 617–20.10.1016/j.amjcard.2003.11.03214996592
]Search in Google Scholar
[
46. Moriguchi J, Itoh H, Harada S, Takeda K, Hatta T, Nakata T, et al. Low frequency regular exercise improves flow-mediated dilatation of subjects with mild hypertension. Hypertens Res 2005; 28(4): 315–21.10.1291/hypres.28.31516138561
]Search in Google Scholar
[
47. Weston KS, Wisloff U, Coombes JS. High-intensity interval training in patients with lifestyle-induced cardiometabolic disease: a systematic review and meta-analysis. Br J Sports Med 2014; 48(16): 1227–34.10.1136/bjsports-2013-09257624144531
]Search in Google Scholar
[
48. Morris JN, Everitt MG, Pollard R, Chave SP, and Semmence AM. Vigorous exercise in leisure-time: protection against coronary heart disease. Lancet 1980; 2: 1207–10..10.1016/S0140-6736(80)92476-9
]Search in Google Scholar
[
49. Davison K, Bircher S, Hill A, Coates AM, Howe PR, Buckley JD. Relationships between obesity, cardiorespiratory fitness, and cardiovascular function. J Obes 2010; 2010: 191253.10.1155/2010/191253303856821331323
]Search in Google Scholar
[
50. Lewis TV, Dart AM, Chin-Dusting JP, Kingwell BA. Exercise training increases basal nitric oxide production from the forearm in hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 1999; 19(11): 2782–7.10.1161/01.ATV.19.11.2782
]Search in Google Scholar
[
51. Tjønna AE, Lee SJ, Rognmo Ø, Stølen TO, Bye A, Haram PM, et al. Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome: a pilot study. Circulation 2008; 118(4): 346–54.10.1161/CIRCULATIONAHA.108.772822
]Search in Google Scholar
[
52. Schjerve IE, Tyldum GA, Tjønna AE, Stølen T, Loennechen JP, Hansen HE, et al. Both aerobic endurance and strength training programmes improve cardiovascular health in obese adults. Clin Sci (London, England: 1979) 2008; 115(9): 283–93.10.1042/CS20070332
]Search in Google Scholar
[
53. Mitranun W, Deerochanawong C, Tanaka H, Suksom D. Continuous vs interval training on glycemic control and macro- and microvascular reactivity in type 2 diabetic patients. Scand J Med Sci Sports 2014; 24(2): e69–76.10.1111/sms.12112
]Search in Google Scholar
[
54. Moore RL and Palmer BM. Exercise training and cellular adaptations of normal and diseased hearts. Exerc Sport Sci Rev 1999; 27: 285–315.10.1249/00003677-199900270-00011
]Search in Google Scholar
[
55. Vujic A, Lerchenmüller C, Wu TD, Guillermier C, Rabolli CP, Gonzalez E, et al. Exercise induces new cardiomyocyte generation in the adult mammalian heart. Nat Commun 2018; 9(1): 1659.10.1038/s41467-018-04083-1
]Search in Google Scholar
[
56. Powers SK, Demirel HA, Vincent HK, Coombes JS, Naito H, Hamilton KL, et al. Exercise training improves myocardial tolerance to in vivo ischemia-reperfusion in the rat. Am J Physiol 1998; 275(5): R1468-77.10.1152/ajpregu.1998.275.5.R1468
]Search in Google Scholar
[
57. Koch LG, Britton SL. Rat Models of Exercise for the Study of Complex Disease. Methods Mol Biol 2019; 2018: 309–17.10.1007/978-1-4939-9581-3_15
]Search in Google Scholar
[
58. O. J. Kemi, J. P. Loennechen, U. Wisløff, O. Ellingsen. Intensity-controlled treadmill running in mice: cardiac and skeletal muscle hypertrophy. J Appl Physiol 2002; 93: 1301-9.10.1152/japplphysiol.00231.2002
]Search in Google Scholar
[
59. Kemi OJ, Haram PM, Wisløff U, Ellingsen Ø. Aerobic fitness is associated with cardiomyocyte contractile capacity and endothelial function in exercise training and detraining. Circulation 2004; 109(23): 2897-904.10.1161/01.CIR.0000129308.04757.72
]Search in Google Scholar
[
60. Wisløff U, Loennechen JP, Currie S, Smith GL, Ellingsen Ø. Aerobic exercise reduces cardiomyocyte hypertrophy and increases contractility, Ca2+ sensitivity and SERCA-2 in rat after myocardial infarction. Cardiovasc Res 2002; 54(1): 162-74.10.1016/S0008-6363(01)00565-X
]Search in Google Scholar
[
61. Lopaschuk GD, Rebeyka IM, and Allard MF. Metabolic modulation: a means to mend a broken heart. Circulation 2002; 105: 140–2.10.1161/circ.105.2.140
]Search in Google Scholar
[
62. Rossello X, He Z, Yellon DM. Myocardial Infarct Size Reduction Provided by Local and Remote Ischaemic Preconditioning: References Values from the Hatter Cardiovascular Institute. Cardiovasc Drugs Ther 2018; 32(2): 127–33.10.1007/s10557-018-6788-8595815729656359
]Search in Google Scholar
[
63. Sciacqua A, Candigliota M, Ceravolo R, Scozzafava A, Sinopoli F, Corsonello A, et al. Weight loss in combination with physical activity improves endothelial dysfunction in human obesity. Diabetes Care 2003; 26(6): 1673–8.10.2337/diacare.26.6.167312766092
]Search in Google Scholar
[
64. Korge P, Honda HM, and Weiss JN. Effects of fatty acids in isolated mitochondria: implications for ischemic injury and cardioprotection. Am J Physiol Heart Circ Physiol 2003; 285: H259–H69.10.1152/ajpheart.01028.2002
]Search in Google Scholar
[
65. Fiuza-Luces C, Santos-Lozano A, Joyner M, Carrera- Bastos P, Picazo O, Zugaza JL, et al. Exercise benefits in cardiovascular disease: beyond attenuation of traditional risk factors. Nat Rev Cardiol 2018; 15(12): 731–43.10.1038/s41569-018-0065-130115967
]Search in Google Scholar
[
66. Thuny F, Lairez O, Roubille F, Mewton N, Rioufol G, Sportouch C, et al. Post-conditioning reduces infarct size and edema in patients with ST- segment elevation myocardial infarction. J. Am. Coll. Cardiol 2012; 59: 2175–81.
]Search in Google Scholar
[
67. Mewton N, Thibault H, Roubille F, Lairez O, Rioufol G, Sportouch C, et al. Postconditioning attenuates no- reflow in STEMI patients. Basic Res. Cardiol 2013; 108: 383.
]Search in Google Scholar
[
68. Pickard JM, Davidson SM, Hausenloy DJ, Yellon DM. Codependence of the neural and humoral pathways in the mechanism of remote ischemic conditioning. Basic Res Cardiol 2016; 111(4): 50.10.1007/s00395-016-0568-z491937027338249
]Search in Google Scholar
[
69. Mora S, Cook N, Buring JE, Ridker PM, Lee IM. Physical activity and reduced risk of cardiovascular events: potential mediating mechanisms. Circulation 2007; 116(19): 2110–8.10.1161/CIRCULATIONAHA.107.729939211738117967770
]Search in Google Scholar
[
70. Benstoem C, Stoppe C, Liakopoulos OJ, Ney J, Hasenclever D, Meybohm P, et al. Remote ischaemic preconditioning for coronary artery bypass grafting (with or without valve surgery). Cochrane Database Syst Rev 2017; (5): CD011719.10.1002/14651858.CD011719.pub3
]Search in Google Scholar
[
71. Hausenloy DJ, Barrabes JA, Botker HE, Davidson SM, Di Lisa F, Downey J, et al. Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery. Basic Res Cardiol 2016; 111(6): 70.10.1007/s00395-016-0588-8507312027766474
]Search in Google Scholar
[
72. Rahbek SK, Farup J, de Paoli F, Vissing K. No differential effects of divergent isocaloric supplements on signaling for muscle protein turnover during recovery from muscle-damaging eccentric exercise. Amino Acids 2015; 47(4): 767–78.10.1007/s00726-014-1907-825559753
]Search in Google Scholar
[
73. Moller AB, Lonbro S, Farup J, Voss TS, Rittig N, Wang J, et al. Molecular and cellular adaptations to exercise training in skeletal muscle from cancer patients treated with chemotherapy. J Cancer Res Clin Oncol 2019; 145(6): 1449–60.10.1007/s00432-019-02911-530968255
]Search in Google Scholar
[
74. Penna C, Alloatti G, Crisafulli A. Mechanisms Involved in Cardioprotection Induced by Physical Exercise. Antioxid Redox Signal 2020; 32(15): 1115–34.10.1089/ars.2019.800931892282
]Search in Google Scholar
